Avai Bio AVAI
OTC AVAI
$0.11 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Avai Bio (AVAI) Research & Development (2025 - 2026)

Avai Bio's (AVAI) quarterly Research & Development came in at -$8804.0 in Q1 2026, down 136.99% quarter-over-quarter from $23804.0 in Q3 2025.

Analysis

Avai Bio (AVAI) Research & Development (2025 - 2026) Analysis & Trends

Avai Bio has disclosed Research & Development across 2 years of filings, most recently posting -$8804.0 for Q1 2026.

  • In Q1 2026, Research & Development changed N/A year-over-year to -$8804.0; the TTM figure through Mar 2026 stood at $15000.0 (changed N/A YoY), while the FY2026 annual figure was $15000.0, changed N/A from the prior year.
  • Research & Development came in at -$8804.0 for Q1 2026 at Avai Bio, down from $23804.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $23804.0 in Q3 2025 to a low of -$8804.0 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Baidu 4.12 Bn -18.28 Bn 1.76 Mn 679.00 Mn
2 Life360 3.41 Bn 3.14 Bn 126.90 Mn 52.31 Mn
3 Soundhound Ai 2.71 Bn 2.50 Bn 27.93 Mn 27.13 Mn
4 C3.ai 1.46 Bn 885.18 Mn 11.32 Mn 49.34 Mn
5 Spectral Capital 455.65 Mn 450.34 Mn 3.28 Mn -
6 Spire Global 430.44 Mn 338.76 Mn 6.16 Mn 8.18 Mn
7 Global AI 147.15 Mn 147.11 Mn 82,446.00 152,811.00
8 Agassi Sports Entertainment 81.18 Mn 81.11 Mn - 91,021.00
9 Veritone 80.87 Mn 68.45 Mn 15.46 Mn 10.30 Mn
10 Avai Bio 18.47 Mn 18.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -8,804.00
Sep 30, 2025 23,804.00